Please ensure Javascript is enabled for purposes of website accessibility

Why Illumina Shares Soared

By Sean Williams - Apr 23, 2013 at 12:36PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A first-quarter earnings beat sends Illumina shares rocketing higher. But, are shares now overvalued?

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Illumina (ILMN 5.95%), a life science diagnostics company, rallied as much as 15% after the company reported better-than-expected first-quarter earnings results.

So what: For the quarter, Illumina reported a 21% boost in revenues to $331 million with an adjusted profit of $0.46 per share. Wall Street had only expected Illumina to post a profit of $0.39 on just $310.7 million in sales. If there were one blemish to the quarter, it was that the company took a $106.9 million charge related to ongoing patent litigation with Syntrix Biosystems.

Now what: Having witnessed Thermo Fisher Scientific scoop up Life Technologies last week, the sector is still abuzz with optimism. While I don't think Illumina is going to be receiving any takeover bids, I'm very intrigued by the outlook for life science diagnostics companies in general with regard to helping personalize cancer care over the remainder of the decade. Illumina appears to be a bit pricey here, but it's certainly a name worth considering for the future.

Craving more input? Start by adding Illumina to your free and personalized watchlist so you can keep up on the latest news with the company.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Illumina, Inc. Stock Quote
Illumina, Inc.
ILMN
$258.06 (5.95%) $14.49

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
344%
 
S&P 500 Returns
120%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.